Funder
Japan Society for the Promotion of Science
Subject
Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine
Reference40 articles.
1. Advancing host-directed therapy for tuberculosis;Wallis;Nature Rev Immunol,2015
2. Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial;Wallis;Lancet Respir Med,2021
3. Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers;Wallis;Lancet Infect Dis,2016
4. Four-month rifapentine regimens with or without moxifloxacin for tuberculosis;Dorman;N Engl J Med,2021
5. 4-Month moxifloxacin containing regimens in the treatment of patients with sputum-positive pulmonary tuberculosis in South India—a randomised clinical trial;Velayutham;Trop Med Int Health,2020
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献